Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Neurology

Demyelinating Disorders

Neuropsychological training of attention improves MS-related fatigue: Results of a randomized, placebo-controlled, double-blind pilot study

European Neurology | Nov 01, 2017 Demyelinating Disorders

Clustering of neuropsychiatric disease in first-degree and second-degree relatives of patients with amyotrophic lateral sclerosis

JAMA Neurology | Oct 27, 2017 Demyelinating Disorders

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingâremitting multiple sclerosis: An 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

Journal of Neurology | Oct 26, 2017 Demyelinating Disorders

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): A randomised, controlled, double-blind, crossover trial

The Lancet | Oct 21, 2017 Demyelinating Disorders

Randomised controlled pilot trial of an exercise plus behaviour change intervention in people with multiple sclerosis: The Step it Up study

BMJ Open | Oct 17, 2017 Demyelinating Disorders

The prevalence and characteristics of epilepsy in patients with multiple sclerosis in Nordland county, Norway

Seizure - European Journal of Epilepsy | Oct 11, 2017 Demyelinating Disorders

Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis

Journal of Neurology, Neurosurgery & Psychiatry | Oct 11, 2017 Demyelinating Disorders

Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis

European Journal of Neurology | Oct 07, 2017 Demyelinating Disorders

Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression

JAMA Neurology | Sep 28, 2017 Demyelinating Disorders

Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality

NeurologyÂ® | Sep 26, 2017 Demyelinating Disorders

« Prev 1 … 26 27 28 29 30 31 32 Next »

Neuropsychological training of attention improves MS-related fatigue: Results of a randomized, placebo-controlled, double-blind pilot study

Clustering of neuropsychiatric disease in first-degree and second-degree relatives of patients with amyotrophic lateral sclerosis

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingâremitting multiple sclerosis: An 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): A randomised, controlled, double-blind, crossover trial

Randomised controlled pilot trial of an exercise plus behaviour change intervention in people with multiple sclerosis: The Step it Up study

The prevalence and characteristics of epilepsy in patients with multiple sclerosis in Nordland county, Norway

Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis

Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis

Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression

Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality

Article: Depression and Anxiety Screening in Primary Care

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Neuropsychological training of attention improves MS-related fatigue: Results of a randomized, placebo-controlled, double-blind pilot study

Clustering of neuropsychiatric disease in first-degree and second-degree relatives of patients with amyotrophic lateral sclerosis

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingâremitting multiple sclerosis: An 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): A randomised, controlled, double-blind, crossover trial

Randomised controlled pilot trial of an exercise plus behaviour change intervention in people with multiple sclerosis: The Step it Up study

The prevalence and characteristics of epilepsy in patients with multiple sclerosis in Nordland county, Norway

Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis

Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis

Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression

Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality

Article: Depression and Anxiety Screening in Primary Care

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Article on Strategies to Reduce Antibiotic Misuse and Address Antimicrobial Resistance

The 1 food geriatricians avoid to live a long, healthy life

Many young adults have high long-term risk for cardiovascular disease, study finds

Select Specialty

Select Topic

Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsingâremitting multiple sclerosis: An 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)